Skip to main content
. 2016 Oct 7;5(4):535–544. doi: 10.1007/s40121-016-0133-y

Fig. 1.

Fig. 1

Distribution of telavancin MICs obtained using the rBMD or original BMD method in a all S. aureus isolates, b MSSA isolates, c MRSA isolates, and d S. aureus isolates with vancomycin MICs ≥1 µg/mL. MIC minimum inhibitory concentration; MRSA methicillin-resistant S. aureus; MSSA methicillin-susceptible S. aureus; rBMD revised broth microdilution; S. aureus Staphylococcus aureus; VAN vancomycin